Alpha 1-antitrypsin deficiency: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Alpha 1-antitrypsin deficiency}} | {{Alpha 1-antitrypsin deficiency}} | ||
{{CMG}}; {{AE}} {{Mazia}} | {{CMG}}; {{AE}} {{Mazia}} | ||
{{SK}}: | |||
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]] | '''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]] | ||
Revision as of 13:16, 2 January 2018
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2] Synonyms and keywords::
For patient information, click here Template:DiseaseDisorder infobox
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alpha 1-antitrypsin deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies